These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7080476)

  • 1. [Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin].
    Byshevskiĭ ASh; Sokolovskiĭ SR
    Vopr Med Khim; 1982; 28(2):30-4. PubMed ID: 7080476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective effect of heparin and phosphatidylserine in exogenous thromboplastinemia].
    Byshevskiĭ ASh; Sokolovskiĭ SR
    Biull Eksp Biol Med; 1982 Dec; 94(12):23-5. PubMed ID: 7150759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anticoagulant effect of phosphatidylserine].
    Tersenov OA; Chabanov MK
    Vopr Med Khim; 1981; 27(5):619-23. PubMed ID: 7314577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of the hypocoagulemic effect and the active principle of a phosphatidylserine-containing anticoagulant].
    Chabanov MK
    Farmakol Toksikol; 1981; 44(4):425-8. PubMed ID: 7286200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo.
    Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS
    Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Formation of a heparin-prothrombin complex].
    Liapina LA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1979; 25(1):41-6. PubMed ID: 425371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new potent heparin. 1 communication: Determinations of anticoagulant activity of a high potency heparin preparation in vivo using dog as an experimental animal and in vitro using dog and human plasma.
    Bhargava AS; Heinick J; Schöbel C; Günzel P
    Arzneimittelforschung; 1980; 30(6):993-6. PubMed ID: 7191280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of TFPI in clotting assays--comparison and combination with other anticoagulants.
    Nordfang O; Kristensen HI; Valentin S; Ostergaard P; Wadt J
    Thromb Haemost; 1993 Sep; 70(3):448-53. PubMed ID: 8259547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The anticoagulant property of a lipoid anticoagulant and the mechanism of its influence on hemocoagulation].
    Byshevskiĭ ASh; Mukhacheva IA
    Biokhimiia; 1976 Mar; 41(3):543-7. PubMed ID: 1276287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
    Webb MS; Johnstone S; Morris TJ; Kennedy A; Gallagher R; Harasym N; Harasym T; Shew CR; Tardi P; Dragowska WH; Mayer LD; Bally MB
    Eur J Pharm Biopharm; 2007 Mar; 65(3):289-99. PubMed ID: 17123800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies.
    Galli M; Beretta G; Daldossi M; Bevers EM; Barbui T
    Thromb Haemost; 1997 Mar; 77(3):486-91. PubMed ID: 9065999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant activated factor VII effectively reverses the anticoagulant effects of heparin, enoxaparin, fondaparinux, argatroban, and bivalirudin ex vivo as measured using thromboelastography.
    Young G; Yonekawa KE; Nakagawa PA; Blain RC; Lovejoy AE; Nugent DJ
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):547-53. PubMed ID: 17762530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of liposomes containing phosphatidylserine by liver cells in vivo and by sinusoidal liver cells in primary culture: in vivo-in vitro differences.
    Kamps JA; Morselt HW; Scherphof GL
    Biochem Biophys Res Commun; 1999 Mar; 256(1):57-62. PubMed ID: 10066422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulant-free Genius haemodialysis using low molecular weight heparin-coated circuits.
    Frank RD; Müller U; Lanzmich R; Groeger C; Floege J
    Nephrol Dial Transplant; 2006 Apr; 21(4):1013-8. PubMed ID: 16326745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [-Anticoagulant drugs-].
    Gulba DC
    Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging anticoagulants: mechanism of action and future potential.
    Klement P; Rak J
    Vnitr Lek; 2006 Mar; 52 Suppl 1():119-22. PubMed ID: 16637459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.